Maria D. Nogueira

Fortaleza, CE, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Deciphering the circadian signature in acute myeloid leukemia: NPAS2 downregulation as a master predictive feature.

Deciphering the circadian signature in acute myeloid leukemia: NPAS2 downregulation as a master predictive feature.

Journal: Blood research

Published: February 28, 2026

Pharmacogenomics Applied to Acute Leukemias: Identifying Clinically Relevant Genetic Variants.

Pharmacogenomics Applied to Acute Leukemias: Identifying Clinically Relevant Genetic Variants.

Journal: Biomedicines

Published: September 22, 2025

WRAP53 is Downregulated in Acute Myeloid Leukemia Patients and Positively Correlates With HTERT Expression.

WRAP53 is Downregulated in Acute Myeloid Leukemia Patients and Positively Correlates With HTERT Expression.

Journal: Cancer reports (Hoboken, N.J.)

Published: April 16, 2025

Evaluation of the Circadian Rhythm Component Cipc (Clock-Interacting Pacemaker) in Leukemogenesis: A Literature Review and Bioinformatics Approach.

Evaluation of the Circadian Rhythm Component Cipc (Clock-Interacting Pacemaker) in Leukemogenesis: A Literature Review and Bioinformatics Approach.

Journal: Clocks & sleep

Published: February 14, 2025

Association of CD38+ Immunophenotyping Biomarker With a Better Prognosis in Elderly Acute Myeloid Leukemia Patients.

Association of CD38+ Immunophenotyping Biomarker With a Better Prognosis in Elderly Acute Myeloid Leukemia Patients.

Journal: Anticancer research

Published: April 08, 2024

Molecular and Clinical Insights in the Increasing Detection of BCR::ABL1 p190+ in Adult Acute Myeloid Leukemia Patients.

Molecular and Clinical Insights in the Increasing Detection of BCR::ABL1 p190+ in Adult Acute Myeloid Leukemia Patients.

Journal: In vivo (Athens, Greece)

Published: March 06, 2024

Validation of Endogenous Control Genes by Real-Time Quantitative Reverse Transcriptase Polymerase Chain Reaction for Acute Leukemia Gene Expression Studies.

Validation of Endogenous Control Genes by Real-Time Quantitative Reverse Transcriptase Polymerase Chain Reaction for Acute Leukemia Gene Expression Studies.

Journal: Genes

Published: December 07, 2023

Telomerase (hTERT) Overexpression Reveals a Promising Prognostic Biomarker and Therapeutical Target in Different Clinical Subtypes of Pediatric Acute Lymphoblastic Leukaemia.

Telomerase (hTERT) Overexpression Reveals a Promising Prognostic Biomarker and Therapeutical Target in Different Clinical Subtypes of Pediatric Acute Lymphoblastic Leukaemia.

Journal: Genes

Published: September 16, 2021

Telomere Length and Hematological Disorders: A Review.

Telomere Length and Hematological Disorders: A Review.

Journal: In vivo (Athens, Greece)

Published: July 27, 2020

Showing 1-9 of 9

Last Updated: 09/26/2026